All In Biotech

Drug Trial Radar · NCT01592786

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Last checked: Nov 20, 2026Latest source record: Aug 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

906

Actual

Start

Jun 2012

Primary completion

Jul 2013

Study completion Aug 2013

Sponsor

Lead sponsor
Forest LaboratoriesAbbVie (ABBV)
Sponsor type
Industry
First posted
May 7, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and tolerability of memantine in pediatric (6-12 years old) patients with autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and to identify responders for participation in a follow-up randomized withdrawal study.

Conditions

  • Autism Spectrum Disorder (ASD)
  • Autism
  • Autistic Disorder
  • Asperger's Disorder
  • Asperger's
  • Pediatric Autism
  • Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Interventions

  • Memantine Hydrochloride (HCl)Drug

    Memantine extended release 3-mg capsules; the dosages studied ranged from 3 - 15 mg/day; weight based dosing in 4 weight groups; oral administration. Dosing is once daily for up to 48 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Confirmed Social Responsiveness Scale (SRS) RespondersTime frame: Visit 1 (Baseline) to Visit 8 (week 48/Final Visit)

Locations

118 sites in 18 countries. Site status is shown where the registry gives one.

  • Forest Investigative Site 068

    Dothan, Alabama

  • Forest Investigative Site 005

    Phoenix, Arizona

  • Forest Investigative Site 055

    Tucson, Arizona

  • Forest Investigative Site 077

    Little Rock, Arkansas

  • Forest Investigative Site 054

    Glendale, California

  • Forest Investigative Site 109

    Imperial, California

  • Forest Investigative Site 066

    Irvine, California

  • Forest Investigative Site 096

    Los Angeles, California

  • Forest Investigative Site 021

    San Francisco, California

  • Forest Investigative Site 026

    Santa Ana, California

  • Forest Investigative Site 002

    Stanford, California

  • Forest Investigative Site 078

    Boulder, Colorado

  • Forest Investigative Site 073

    Centennial, Colorado

  • Forest Investigative Site 052

    Washington D.C., District of Columbia

  • Forest Investigative Site 075

    Bradenton, Florida

  • Forest Investigative Site 080

    Gainesville, Florida

  • Forest Investigative Site 117

    Jacksonville, Florida

  • Forest Investigative Site 065

    Maitland, Florida

  • Forest Investigative Site 118

    Miami, Florida

  • Forest Investigative Site 085

    Oakland Park, Florida

  • Forest Investigative Site 115

    Orange City, Florida

  • Forest Investigative Site 124

    Orlando, Florida

  • Forest Investigative Site 125

    Orlando, Florida

  • Forest Investigative Site 062

    Orlando, Florida

  • Forest Investigative Site 114

    Orlando, Florida

  • Forest Investigative Site 067

    Tampa, Florida

  • Forest Investigative Site 101

    Wellington, Florida

  • Forest Investigative Site 102

    Libertyville, Illinois

  • Forest Investigative Site 023

    Naperville, Illinois

  • Forest Investigative Site 082

    Evansville, Indiana

  • Forest Investigative Site 123

    Fort Wayne, Indiana

  • Forest Investigative Site 056

    Indianapolis, Indiana

  • Forest Investigative Site 084

    Indianapolis, Indiana

  • Forest Investigative Site 106

    Wichita, Kansas

  • Forest Investigative Site 061

    Louisville, Kentucky

  • Forest Investigative Site 074

    Owensboro, Kentucky

  • Forest Investigative Site 095

    Lake Charles, Louisiana

  • Forest Investigative Site 091

    New Orleans, Louisiana

  • Forest Investigative Site 086

    Rockville, Maryland

  • Forest Investigative Site 059

    Newton, Massachusetts

Showing 40 of 118 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.